Stay updated with breaking news from Lal Pathlab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q1 results today: A total of 65 listed companies including Bajaj Finserv, BEL, Shriram Finance, IHC are going to report their Q1 results 2023
Dr Lal PathLabs has given a breakout of Mother candle of May 12 with bullish candlestick pattern formation and significantly higher volumes. The stock has touched 200-day EMA (Rs 2,140) intraday and finally settled at Rs 2,121, up 4.7 percent.
Dr Lal PathLabs recorded a decline of 7.5 per cent, reporting a net profit of INR 56.7 crore in the quarter ended in March 2023, compared to Rs 61.3 crore in the same quarter last year, , dr lal pathlabs, finance, stock market
New Delhi [India], March 15 (ANI/NewsVoir): Dr Lal PathLabs Limited, one of India's leading pathology diagnostic providers with more than 250 laboratories and 4500 sample collection points, has appointed Kyndryl (NYSE: KD), the world's largest IT infrastructure services provider, to manage its IT infrastructure stack, including both the on-premises IT environment and cloud infrastructure across multiple hyperscaler cloud service providers. Post onboarding, Kyndryl has been instrumental in managing the multiple cloud platforms that play a key role in Dr Lal PathLabs' digital transfo...
Dr. Lal PathLabs Ltd has appointed Kyndryl, to manage its IT infrastructure stack, including both the on-premises IT environment and cloud infrastructure across multiple hyperscaler cloud service providers.